Clinical Trials

CONCLUSIONS: In children hospitalised with confirmed or suspected bacterial infection, the addition of a procalcitonin-guided algorithm to usual care is non-inferior in terms of safety, but does not reduce duration of intravenous antibiotics, and is not cost-effective. In the presence of robust antimicrobial stewardship programmes to reduce antibiotic use, a procalcitonin-guided algorithm may offer little…

Read more →

This study aims to conduct a single-blind randomized controlled trial to evaluate the bleaching efficacy and tooth sensitivity (TS) following the use of violet LED associated or not with 35% hydrogen peroxide. Eighty-four participants were randomly allocated into three groups according to bleaching treatments (n = 28): 35% hydrogen peroxide (HP) only, Violet LED only…

Read more →

CONCLUSION: A nurse-led health promotion educational program was effective in improving glucose and high-density lipoprotein cholesterol levels among adults with type 2 diabetes and metabolic syndrome, as well as reducing the number of metabolic syndrome components in the participants.

Read more →

CONCLUSION: Customized orthoses effectively improved foot morphology and reduced plantar pressure in professional athletes with ANS compared to conventional insoles. These findings suggest that customized orthotic intervention provides faster and more significant pain relief for patients with ANS-related medial arch collapse.

Read more →

CONCLUSION: According to the current study it has been concluded that there was no remarkable difference between the outcomes of both methods. The study protocol and its consent form were approved by the ethical committee of Suez Canal University (No.432/2021); and registered retrospectively on 23 April 2024 on PACTR (PACTR20240875463218) (pactr.samrc.ac.za/TrialDisplay.aspx?TrialID = 30442).

Read more →

CONCLUSION: Combination therapy with calcium dobesilate and ranibizumab decreased the frequency of intravitreal injections and led to greater improvements in BCVA and CMT compared to ranibizumab alone over 12 months. Both treatments were well-tolerated, with the combination therapy demonstrating a favorable safety profile.

Read more →

The KIADEKU project combines datascience and the clinical expertise of wound experts to develop and evaluate an AI-application for incontinence-associated-dermatitis (IAD) and pressure ulcer (PU) wound care. The evaluation study is a controlled, non-randomized clinical trial that investigates the effects of the AI-based system on wound care time, guideline adherence and the task load of…

Read more →

Background: Hereditary angioedema (HAE) is associated with substantial health-related quality of life (HRQoL) impairments. Complete disease control and life normalization are key treatment goals. In previous studies, garadacimab prevented HAE attacks with a favorable safety profile and HRQoL improvements. Objective: HRQoL was evaluated in patients with HAE receiving garadacimab stratified by attack-free status. Methods: In…

Read more →

Background: Hereditary angioedema (HAE) attacks substantially impair health-related quality of life (HRQoL). Current World Allergy Organization and the European Academy of Allergy and Clinical Immunology guidelines goals include complete control and normalization of patients’ lives. Garadacimab (anti-activated factor XII monoclonal antibody) reduced the mean attack rate after first administration in the pivotal phase III (VANGUARD;…

Read more →

Background: The cost-effectiveness of school environmental remediation in asthma is not known. The School Inner City Asthma Intervention Study (SICAS2) was a randomized controlled trial that assessed school integrated pest management (IPM) and classroom high efficiency particulate air (HEPA) filtration on asthma morbidity in urban schools. Objective: The objective was to evaluate the cost-effectiveness of…

Read more →